Literature DB >> 21899694

CHD6 chromatin remodeler is a negative modulator of influenza virus replication that relocates to inactive chromatin upon infection.

Roberto Alfonso1, Thomas Lutz, Ariel Rodriguez, J Pablo Chavez, Paloma Rodriguez, Silvia Gutierrez, Amelia Nieto.   

Abstract

The influenza virus establishes close functional and structural connections with the nucleus of the infected cell. Thus, viral ribonucleoproteins (RNPs) are closely bound to chromatin components and the main constituent of viral RNPs, the nucleoprotein (NP) protein, interacts with histone tails. Using a yeast two-hybrid screening, we previously found that the PA influenza virus polymerase subunit interacts with the CHD6 protein, a member of the CHD family of chromatin remodelers. Here we show that CHD6 also interacts with the viral polymerase complex and colocalizes with viral RNPs in the infected cells. To study the relationships between RNPs, chromatin and CHD6, we have analysed whether NP and CHD6 binds to peptides representing trimethylated lysines of histone 3 tails that mark transcriptionally active or inactive chromatin. Upon infection, NP binds to marks of repressed chromatin and, interestingly an important recruitment of CHD6 to these heterochromatin marks occurs in this situation. Silencing experiments indicate that CHD6 acts as a negative modulator of influenza virus replication. Hence, the CHD6 association with inactive chromatin could be part of a process where the influenza virus triggers modifications of chromatin-associated proteins that could contribute to the pathogenic events used by the virus to induce host cell shut-off.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21899694     DOI: 10.1111/j.1462-5822.2011.01679.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  20 in total

1.  The Global Phosphorylation Landscape of SARS-CoV-2 Infection.

Authors:  Mehdi Bouhaddou; Danish Memon; Bjoern Meyer; Kris M White; Veronica V Rezelj; Miguel Correa Marrero; Benjamin J Polacco; James E Melnyk; Svenja Ulferts; Robyn M Kaake; Jyoti Batra; Alicia L Richards; Erica Stevenson; David E Gordon; Ajda Rojc; Kirsten Obernier; Jacqueline M Fabius; Margaret Soucheray; Lisa Miorin; Elena Moreno; Cassandra Koh; Quang Dinh Tran; Alexandra Hardy; Rémy Robinot; Thomas Vallet; Benjamin E Nilsson-Payant; Claudia Hernandez-Armenta; Alistair Dunham; Sebastian Weigang; Julian Knerr; Maya Modak; Diego Quintero; Yuan Zhou; Aurelien Dugourd; Alberto Valdeolivas; Trupti Patil; Qiongyu Li; Ruth Hüttenhain; Merve Cakir; Monita Muralidharan; Minkyu Kim; Gwendolyn Jang; Beril Tutuncuoglu; Joseph Hiatt; Jeffrey Z Guo; Jiewei Xu; Sophia Bouhaddou; Christopher J P Mathy; Anna Gaulton; Emma J Manners; Eloy Félix; Ying Shi; Marisa Goff; Jean K Lim; Timothy McBride; Michael C O'Neal; Yiming Cai; Jason C J Chang; David J Broadhurst; Saker Klippsten; Emmie De Wit; Andrew R Leach; Tanja Kortemme; Brian Shoichet; Melanie Ott; Julio Saez-Rodriguez; Benjamin R tenOever; R Dyche Mullins; Elizabeth R Fischer; Georg Kochs; Robert Grosse; Adolfo García-Sastre; Marco Vignuzzi; Jeffery R Johnson; Kevan M Shokat; Danielle L Swaney; Pedro Beltrao; Nevan J Krogan
Journal:  Cell       Date:  2020-06-28       Impact factor: 41.582

2.  The Cellular Factor NXP2/MORC3 Is a Positive Regulator of Influenza Virus Multiplication.

Authors:  Lorena S Ver; Laura Marcos-Villar; Sara Landeras-Bueno; Amelia Nieto; Juan Ortín
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

Review 3.  Snapshots: chromatin control of viral infection.

Authors:  David M Knipe; Paul M Lieberman; Jae U Jung; Alison A McBride; Kevin V Morris; Melanie Ott; David Margolis; Amelia Nieto; Michael Nevels; Robin J Parks; Thomas M Kristie
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

4.  CHD6, a cellular repressor of influenza virus replication, is degraded in human alveolar epithelial cells and mice lungs during infection.

Authors:  Roberto Alfonso; Ariel Rodriguez; Paloma Rodriguez; Thomas Lutz; Amelia Nieto
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

5.  Influenza Virus and Chromatin: Role of the CHD1 Chromatin Remodeler in the Virus Life Cycle.

Authors:  Laura Marcos-Villar; Alejandra Pazo; Amelia Nieto
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

6.  Exploration of binary virus-host interactions using an infectious protein complementation assay.

Authors:  Sandie Munier; Thomas Rolland; Cédric Diot; Yves Jacob; Nadia Naffakh
Journal:  Mol Cell Proteomics       Date:  2013-07-01       Impact factor: 5.911

7.  Transcriptional derepression of the ERVWE1 locus following influenza A virus infection.

Authors:  Fang Li; Christoffer Nellåker; Sarven Sabunciyan; Robert H Yolken; Lorraine Jones-Brando; Anne-Sofie Johansson; Björn Owe-Larsson; Håkan Karlsson
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

Review 8.  Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis.

Authors:  Aartjan J W Te Velthuis; Ervin Fodor
Journal:  Nat Rev Microbiol       Date:  2016-07-11       Impact factor: 60.633

9.  Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses.

Authors:  Vineet D Menachery; Amie J Eisfeld; Alexandra Schäfer; Laurence Josset; Amy C Sims; Sean Proll; Shufang Fan; Chengjun Li; Gabriele Neumann; Susan C Tilton; Jean Chang; Lisa E Gralinski; Casey Long; Richard Green; Christopher M Williams; Jeffrey Weiss; Melissa M Matzke; Bobbie-Jo Webb-Robertson; Athena A Schepmoes; Anil K Shukla; Thomas O Metz; Richard D Smith; Katrina M Waters; Michael G Katze; Yoshihiro Kawaoka; Ralph S Baric
Journal:  mBio       Date:  2014-05-20       Impact factor: 7.867

10.  Epigenetic repression of herpes simplex virus infection by the nucleosome remodeler CHD3.

Authors:  Jesse H Arbuckle; Thomas M Kristie
Journal:  mBio       Date:  2014-01-14       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.